Renowned Scientist, Tom
Blumenthal, takes the helm of
Linda Crnic Institute for
Down Syndrome
DENVER (July 2, 2012) – Nationally
renowned molecular biologist, Tom Blumenthal, Ph.D, has been named the new
Executive Director of the Linda Crnic Institute for Down Syndrome headquartered
at the University of Colorado School of Medicine, Anschutz Medical Campus.
Dr. Blumenthal, who is leaving his post as
Chairman of the Molecular, Cellular and Developmental Biology Department at the
University of Colorado Boulder, brings an impressive track record of academic
management and basic science experience to his new role.
“Morally I believe we are obligated to help
people through scientific study.
Scientifically I am intrigued with the Crnic Institute’s mission to
eradicate the medical and cognitive ill effects associated with Down syndrome,”
said Blumenthal. “Given current technological advances I believe we have a
fighting chance at delivering. My first focus will be to dramatically increase
the amount of research the Crnic Institute is engaged in, and to initiate a
competitive Grand Challenges grant program within the University of Colorado
system.”
Dr. Blumenthal is no stranger to the Crnic
Institute’s mission. From its inception he has served on the Crnic Institute’s
Scientific Advisory Board and for the past year on the Board of Directors.
“We are excited about the leadership, scientific
knowledge, professionalism and passion Dr. Blumenthal brings to the Crnic
Institute,” said John J. Sie, co-trustee of the Anna and John J. Sie Foundation
and founding donor of the Crnic Institute. “With Tom at the helm, we are
confident our $22 million donation will create unprecedented excellent quality
medical care but also important basic research benefitting people with Down
syndrome.”
Michelle Sie Whitten, Executive Director of the
Global Down Syndrome Foundation, which provides fundraising, education,
awareness and government advocacy for the Crnic Institute agrees. “Dr.
Blumenthal has already started major research initiatives that we can galvanize
our community around, fundraise for and educate society about. We couldn’t be
more excited.”
Lilly Marks, a Crnic Institute Board of Directors
Member, Vice President for Health Affairs University of Colorado and Executive
Vice Chancellor of the Anschutz Medical Campus welcomes her distinguished
colleague. “Tom’s deep network of scientific colleagues on both campuses puts
him in a unique position to galvanize research benefitting people with Down
syndrome. He has the scientific leadership that is important for a multidisciplinary,
multi-campus effort to ameliorate the adverse effects of Down syndrome.”
Dr. Blumenthal served as
two-term Chair for the Department of Molecular, Cellular and Developmental
Biology at University of Colorado Boulder. Prior to that he was the Chair of
Biochemistry and Molecular Genetics at the University of Colorado Health
Sciences Center for eight years, and before that Chair of Biological Sciences
at Indiana University, Bloomington, for many years.
Dr. Blumenthal earned his undergraduate degree
in Biology at Antioch College in 1966. He was a National Science Foundation
fellow during his graduate work at Johns Hopkins University, from which he
received his PhD in Genetics in 1970. He was awarded the Helen Hay Whitney
Foundation Postdoctoral Fellowship, which he completed at Harvard University’s
Department of Biochemistry and Molecular Biology in 1973. Dr. Blumenthal is the
author of more than 100 scholarly articles and one book, and currently sits on
the editorial boards of the journals RNA,
Molecular and Cellular Biology, Transcription and Worm, in addition to the
online book, Wormbook.
He has served on the Board of Directors of the
American Medical and Graduate Departments of Biochemistry, the American Society
of Biochemistry and Molecular Biology, the RNA Society and the Scientific
Advisory Board of Wormbase, the C.
elegans database. He also served as a member of the University of
California Science and Technology Committee and the Scientific Advisory Boards
of the Biological Science Divisions of the Los Alamos and Lawrence Livermore
National Laboratories. He was elected to membership in the American Academy of
Arts and Sciences in 2010.
Dr. Blumenthal’s research in the area of gene
expression concentrates on mechanisms of pre-mRNA processing in C. elegans and how that relates to organization
of genes on chromosomes. Dr. Blumenthal’s work with the C. elegans model system even has possibly significant implications
for understanding Down syndrome, despite its seemingly distinct focus. Dr.
Blumenthal emphasizes that, “We do not currently understand how an extra copy
of chromosome 21 results in all the many effects seen in people with Down
syndrome, but dramatic changes in gene expression may be the most likely
explanation.” Dr. Blumenthal is excited to have the opportunity to facilitate
putting together research teams to test ideas like this both to understand the
causes of, and the benefit to those who have, Down syndrome.
About the Linda Crnic Institute
for Down Syndrome
The Linda Crnic Institute for Down Syndrome is the first medical and research institute
with the mission to provide the best clinical care to people with Down
syndrome, and to eradicate the medical and cognitive ill effects associated
with the condition. Established in 2008, the Crnic Institute is a partnership
between the University of Colorado School of Medicine, the University of Colorado
Boulder, and Children’s Hospital
Colorado.
Headquartered on the Anschutz Medical Campus, the Crnic Institute includes the
Anna and John J. Sie Center for Down Syndrome at the Children’s Hospital
Colorado. It partners both locally and globally to provide life-changing
research and medical care for individuals with Down syndrome. The Crnic
Institute is made possible by the generous support of the Anna and John J. Sie
Foundation, and relies on the Global Down Syndrome Foundation for fundraising,
education, awareness and government advocacy. It is a research and
medical-based organization without political or religious affiliation or
intention.
The Global Down Syndrome Foundation is a public
non-profit 501(c)(3) dedicated to significantly improving the lives of people
with Down syndrome through research, medical care, education and advocacy. Formally established in 2009, the
Foundation’s primary focus is to support the Linda Crnic Institute
for Down Syndrome, the first academic home in the US committed to research and
medical care for people with the condition. Fundraising and government advocacy
that corrects the alarming disparity of national funding for people with Down
syndrome is a major short-term goal. The Foundation organizes the Be Beautiful
Be Yourself Fashion Show - the single largest annual fundraiser benefitting
people with Down syndrome. Programmatically the Foundation organizes and funds
many programs and conferences including the Dare to Play Football and Cheer
Camps, Global Down Syndrome Educational Series, and Global Down Syndrome Multi-Language
Resource Project. The Foundation is an inclusive organization without political
or religious affiliation or intention.
No comments:
Post a Comment